May 19, 2020
MGB Biopharma Announces Successful Outcome From Phase II Clinical Study with MGB-BP-3 - a Potential New Gold Standard, First-line Treatment for Clostridium difficile Infection (CDI)
Nov 12, 2019
Raising Awareness of Rampant Deadly Infection, "See C. diff" Campaign Aims to Save Lives
Oct 01, 2019
Microbiome Therapeutics Innovation Group Highlights Member Company Activity at IDWeek 2019
Jan 24, 2019
MGB Biopharma - FDA and Health Canada Clear IND/CTA Applications for MGB-BP-3, a Novel, Potent Bactericidal Antibiotic Targeting Clostridium difficile-Associated Diarrhoea (CDAD)
Jan 16, 2019
Acurx Receives FDA Fast Track Designation for ACX-362E for the Treatment of C. difficile infection
Nov 21, 2018
Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development
Oct 15, 2018
Fairfield Medical Center Achieves a Major Patient Safety Milestone
Oct 01, 2018
Ecolab Obtains First-to-Market EPA-Registered Laundry Disinfectant Claim against Clostridium difficile
Jun 08, 2018
Microbiome Health Index(TM) Platform, Outcomes of Rebiotix's RBX7455 Oral Formulation To Be Featured in Rapid Fire and Poster Sessions at ASM Microbe 2018
Jun 04, 2018
Rebiotix Microbiota Restoration Therapy(TM) Products, Microbiome Health Index(TM) to Take Center Stage at Digestive Disease Week 2018
Feb 26, 2018
TECHLAB® Products Identified As Meeting Updated Clinical Practice Guidelines For Clostridium Difficile Infection
Feb 20, 2018
New IDSA/SHEA Guidelines Highlight Critical Role of PCR Testing in C. difficile Diagnosis
Feb 12, 2018
Rebiotix Develops Microbiome Health Index(TM) to Identify Indicators for Microbiome Restoration
Feb 05, 2018
Worldwide Clostridium Difficile Infection Treatment Market to Reach US$ 1,316.7 Mn by 2025 - Persistence Market Research
Jan 09, 2018
Rebiotix Highlights 2017 Achievements and 2018 Objectives
Jan 05, 2018
Rebiotix and CoreBiome Collaborate on Evaluating Microbiomes of Patients Treated with Microbiota Restoration Therapy(TM)
Nov 28, 2017
GenePOC Launches its GenePOC(TM) CDiff Test in the United States
Nov 15, 2017
Rebiotix to Present at 29th Annual Piper Jaffray Healthcare Conference
Nov 02, 2017
Rebiotix and the C Diff Foundation Applaud the State of Minnesota as it Declares November C. Difficile Infection Awareness Month
Nov 01, 2017
CutisPharma and C Diff Foundation Announce Partnership to Kick Off Clostridium difficile Awareness Month